Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Juan M. Mejia Vilet"'
Autor:
Isabelle Ayoub, John P. Shapiro, Huijuan Song, Xiaolan Lily Zhang, Samir Parikh, Salem Almaani, Sethu Madhavan, Sergey V. Brodsky, Anjali Satoskar, Cherri Bott, Lianbo Yu, Michael Merchant, John Klein, Juan M. Mejia-Vilet, Tibor Nadasdy, Dan Birmingham, Brad H. Rovin
Publikováno v:
Kidney International Reports, Vol 6, Iss 2, Pp 484-492 (2021)
Introduction: Membranous nephropathy (MN) is a common cause of adult nephrotic syndrome that progresses to end-stage kidney disease in up to 40% of cases. It is an autoimmune disease characterized by glomerular subepithelial deposits containing IgG.
Externí odkaz:
https://doaj.org/article/c00a7fe67c1a4fd98f948276fdcb3a76
Autor:
Samir V. Parikh, Ana Malvar, John Shapiro, James M. Turman, Huijuan Song, Valeria Alberton, Bruno Lococo, Juan M. Mejia-Vilet, Sethu Madhavan, Jianying Zhang, Lianbo Yu, Anjali A. Satoskar, Dan Birmingham, Wael N. Jarjour, Brad H. Rovin, Latha P. Ganesan
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The mechanisms that promote local inflammatory injury during lupus nephritis (LN) flare are largely unknown. Understanding the key immune cells that drive intrarenal inflammation will advance our knowledge of disease pathogenesis and inform the devel
Externí odkaz:
https://doaj.org/article/63065371f643446abad34eaa74a0458d
Publikováno v:
Kidney International. 101:242-255
Over the past year, and for the first time ever, the US Food and Drug Administration approved 2 drugs specifically for the treatment of lupus nephritis (LN). As the lupus community works toward understanding how to best use these new therapies, it is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6632af6e2b8e73ac65a94d0484f7350
https://doi.org/10.1016/j.kint.2021.09.012
https://doi.org/10.1016/j.kint.2021.09.012
Autor:
Meryl Waldman, Ninet Sinaii, Edgar V. Lerma, Anila Abraham Kurien, Kenar D. Jhaveri, Nupur N. Uppal, Rimda Wanchoo, Rupali Avasare, Jonathan E. Zuckerman, Adrian Liew, Alexander J. Gallan, Ashraf El-Meanawy, Yoram Yagil, Larissa Lebedev, Krishoban Baskaran, Eswari Vilayur, Adrienne Cohen, Nethmi Weerasinghe, Ioannis Petrakis, Kostas Stylianou, Hariklia Gakiopoulou, Alexander J. Hamilton, Naomi Edney, Rachel Millner, Smaragdi Marinaki, Joshua L. Rein, John Paul Killen, Jose Manuel Rodríguez Chagolla, Claude Bassil, Ramon Lopez del Valle, Jordan Evans, Anatoly Urisman, Mona Zawaideh, Pravir V. Baxi, Roger Rodby, Mahesha Vankalakunti, Juan M. Mejia Vilet, Silvia E. Ramirez Andrade, Mal P. Homan, Enzo Vásquez Jiménez, Natasha Perinpanayagam, Juan Carlos Q. Velez, Muner M.B. Mohamed, Khalid M.G. Mohammed, Arjun Sekar, Laura Ollila, Abraham W. Aron, Kevin Javier Arellano Arteaga, Mahmud Islam, Esperanza Moral Berrio, Omar Maoujoud, Rebecca Ruf Morales, Regan Seipp, Carl E. Schulze, Robert H. Yenchek, Irina Vancea, Muhammad Muneeb, Lilian Howard, Tiffany N. Caza
Publikováno v:
Waldman, M, Sinaii, N, Lerma, E V, Abraham Kurien, A, Jhaveri, K, Uppal, N, Hamilton, A J & et, A 2022, ' COVID-19 Vaccination and new onset glomerular disease: Results from the IRocGN2 International registry ', Kidney360 . https://doi.org/10.34067/KID.0006832022
ORIGINAL INVESTIGATIONCOVID-19 Vaccination and new onset glomerular disease: Results from the IRocGN2 International registryWaldman, Meryl1,a; Sinaii, Ninet2; Lerma, Edgar V.3; Kurien, Anila Abraham4; Jhaveri, Kenar D.5; Uppal, Nupur N.5; Wanchoo, Ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304698aa115bda5dc9cdfc646802ee62
https://research-information.bris.ac.uk/ws/files/353351393/IRocGN2.pdf
https://research-information.bris.ac.uk/ws/files/353351393/IRocGN2.pdf
Autor:
Frank Bridoux, David Jayne, Yusuke Suzuki, Amy Earley, Kelly A. Burdge, Marina Vivarelli, Zhihong Liu, Jai Radhakrishnan, Adrian Liew, Keisha L. Gibson, Marcello Tonelli, Richard J. Glassock, Sydney C.W. Tang, Sharon G. Adler, Jan-Stephan F. Sanders, H. Terence Cook, Jonathan C. Craig, Vladimir Tesar, Sanjeev Sethi, Jonathan Barratt, Pierre Ronco, Elizabeth M. Rave, Michael Cheung, Brad H. Rovin, David J. Tunnicliffe, Carla M. Nester, Juan M. Mejia-Vilet, Vivekanand Jha, Martin Howell, Fernando C. Fervenza, Tak Mao Chan, Lyubov Lytvyn, Jürgen Floege, Jack F.M. Wetzels, Heather N. Reich
Publikováno v:
Kidney International, 100, 753-779
Kidney International, 100(4), 753-779. ELSEVIER SCIENCE INC
Kidney International, 100, 4, pp. 753-779
Kidney international 100(4), 753-779 (2021). doi:10.1016/j.kint.2021.05.015
Kidney International, 100(4), 753-779. ELSEVIER SCIENCE INC
Kidney International, 100, 4, pp. 753-779
Kidney international 100(4), 753-779 (2021). doi:10.1016/j.kint.2021.05.015
Kidney international 100(4), 753-779 (2021). doi:10.1016/j.kint.2021.05.015
Published by Elsevier, New York, NY
Published by Elsevier, New York, NY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d99a08efc64978a4350a60dee90dad55
https://doi.org/10.1016/j.kint.2021.05.015
https://doi.org/10.1016/j.kint.2021.05.015
Publikováno v:
Expert Review of Clinical Immunology. 17:937-945
Introduction Kidney survival rates in lupus nephritis (LN) remain suboptimal, with 10-20% of patients progressing to end-stage kidney disease by 10 to 20 years. Recently, the landscape of LN management has changed with the advent of new molecules tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4cf888d80e6d2d4625c2d8d82d0904
https://doi.org/10.1080/1744666x.2021.1967747
https://doi.org/10.1080/1744666x.2021.1967747
Autor:
Norma O. Uribe-Uribe, Silvia E. Ramirez-Andrade, Roque A Comunidad-Bonilla, Megan A Navarro-Gerrard, Abraham Cohen-Bucay, Juan M. Mejia-Vilet
Publikováno v:
Journal of Onco-Nephrology. 5:140-144
Crystalcryoglobulinemia refers to the extracellular deposition of crystals in the systemic vasculature, leading to vascular injury, thrombosis, and occlusion. This entity is usually described as a complication of multiple myeloma, although it can als
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f70859f52d3a224e8672b708a192c257
https://doi.org/10.1177/23993693211027876
https://doi.org/10.1177/23993693211027876
Autor:
M. F. Z. Miranda, M. A. N. Gerrard, Luis E. Morales-Buenrostro, Ricardo Correa-Rotter, Juan M. Mejia-Vilet
Publikováno v:
J Am Soc Nephrol
Background: The SARS-CoV-2 pandemic has strained healthcare systems worldwide. Increasing age and comorbidities, as CKD are associated with worse outcomes. Information is needed to assist the decision-making process for ICU admission. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47aa1271c850b5d5c0f6ab7330083bf5
https://doi.org/10.1681/asn.2020101472
https://doi.org/10.1681/asn.2020101472
Autor:
Sergey V. Brodsky, John P. Shapiro, Xiaolan Lily Zhang, Salem Almaani, Michael L. Merchant, Anjali A. Satoskar, Cherri Bott, John Klein, Juan M. Mejia-Vilet, Daniel J. Birmingham, Brad H. Rovin, Samir V. Parikh, Lianbo Yu, Tibor Nadasdy, Sethu Madhavan, Huijuan Song, Isabelle Ayoub
Publikováno v:
Kidney International Reports, Vol 6, Iss 2, Pp 484-492 (2021)
Kidney International Reports
Kidney International Reports
Introduction Membranous nephropathy (MN) is a common cause of adult nephrotic syndrome that progresses to end-stage kidney disease in up to 40% of cases. It is an autoimmune disease characterized by glomerular subepithelial deposits containing IgG. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505a700449cc0aa28845e764372ca3db
https://doi.org/10.1016/j.ekir.2020.11.032
https://doi.org/10.1016/j.ekir.2020.11.032
Autor:
Olynka Vega-Vega, Nathan Berman-Parks, Jorge E. Gaytan-Arocha, Ricardo Correa-Rotter, R Angélica Méndez-Pérez, Juan C. Ramirez-Sandoval, Mauricio Arvizu-Hernandez, Roque A Comunidad-Bonilla, Juan M. Mejia-Vilet, Dheni A. Fernández-Camargo, Rigoberto D. Álvarez, Areli Flores-Camargo, Armando J. Martínez-Rueda
Publikováno v:
Blood Purification
Introduction: Acute kidney injury (AKI) is common in coronavirus disease 2019 (COVID-19). It is unknown if hospital-acquired AKI (HA-AKI) and community-acquired AKI (CA-AKI) convey a distinct prognosis. Methods: The study aim was to evaluate the inci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5b917697db7be86d725260cf318f7c
https://doi.org/10.1159/000513948
https://doi.org/10.1159/000513948